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SYN  251 
Re-examined  proposal  for  a  Counci 1 Directive 
widening  the  scope  of  Directives  65/65/EEC  and  75/319/EEC. 
on  the  apprbximation  of  provisions  laid  down  by  law, 
regulation  or  administrative  action .. 
relating  to  proprietary  medicinal  products 
and  establishing  complem~ntary provisions 
for  homoeopathic  medicines. 
On  8  July  1~92,  the  European  Parliament  examined  the  Common  ~ 
..• -. 
Position  reached  by  the  Council  on  25  February  1992  in  the  light  of 
the  proposal  mentioned  her~under.  The  Parliament  adopted  nin~ 
amendments. 
In  acc~rda~~e with  Article  149(2l<dl  of  the  Treaty,  the  Commission 
'•  •  A 
has  re:-examined  its  proposal  and  decided  to  take  all  the  amendments 
ado~ted  b~ the  Parliamerit  on  S~c~nd.Rea~ing with  the  exception  of 
amendment~ 3,  ~  ~nd 10,  which  it  ~ejected for  the  reasons  explained 
below.  The  amendments  accepted  by  the  Commission  are  set  out  in 
Annex  1.  The  amendments  rejected  by  the  Commission  are  at  Annex  2. 
The  purpose  of  Amendment  3  was  to  clarify  the  concept  of 
homoeopathic  medicine.  In  the  opinion  of  the  Commission  however, 
this  modification  would  have  the  effect  of  including,  within  the 
framework  of  the  simplified  registration  procedure,  preparations 
with  a  higher  concentration  of  active  principle;  the  potential 
risks  of  toxicity  from  these  preparations  must  be  assessed  in 
accordance  with  the  procedure  set  out  at  Article  9  of  the  Directive. Amendment  5  was  aimed  at  permitting,  by  derogation  from  Article  7 
paragraph  2  first  indent  of  the .Common  Position,  the  use  of  a  · 
brqnd  name.for  homoeopathic  medicines·containing.several ·active 
componen~s.  The  Commission .has·not  taken  this  amendment  on  board 
since· it considers ·that  the  pres  entation  o'f  several  active · 
components  simply  under  a  brand  name  gives ·the. impression  of.  a. 
therapeutic  effect.,  whereas .the  procedure  in  Article  7  app'l.ies-··only 
:to  ho.moeopathic  medicines· which  are  marketed· without,a· 'therapeu•ti'c 
indication  . 
.  AmendQJent  1.0  would  have  required ·the  Commission  to  dev'elop~ a 
,_, ..  CO.!Dple.te  ·policy  cover.ing  medicines  described. as  "alternative".·"-Suc·h· 
an  arrangement: would  cl·early ·go  beyond  .the -scope  of  this .pro·posa>l, ·· 
which., is  ..  concerned -.with  the. ,free  c ircul  at·ion ·of  m.e<itc inal ·proa-uc ts, 
and··not. the. methods  of  tra~ning,._for· and  ex ere i-se  of. the  a:s·soc iated · . 
. ,t·.J:le r.api es,  a·· f i'eld  in. whi-ch .·Community  c:ompe.tenc:e  woul.d  be ·.d-i ff  -icul t, 
to  justify. 
.. 
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ANNEX  1  :  AMENDEMENTS  ACCEPT~D BY  THE  COMMISSION 
Common  position of  the  Council  Text  as  amended  by  Pari iament 
Article  ~(2)a  (new) 
2a.  A  homeopathic  preparation  may 
contain.  with  the  exception  of 
catalysts.  only  homeopathic  basic 
substances  in  a  minimum  dilution  of 
.1...;_!Q_,_ 
Article 7(2),  introductory clause 
2.  In  addition  to  the  clear 
mention  of  the  words  "homeopathic 
medicinal  product  registered  under  a 
special,  simplified  procedure",  the 
-labelling  and,  where  appropri.ate, 
package  insert  for  the  . medicinal 
products  referred  to  in  paragraph  1 
shall  bear  the  following,  -and  no 
other,  information: 
2.  In  addition  to  the  clear 
mention  of  the  words  "homeopathic 
medicinal  product·~  the  ·labelling 
and,  where  a·pprop.rtate,  ·package 
insert  for  the  medici:nal  products 
referred  to  in  paragrap'h  1  shall 
bear ·the  following,  and  ·no  ·other, 
information: 
Article 7(2),  eleventh  indent 
"homeopathic  medicinal  product 
without  approved  therapeutic 
indications" 
Deleted 
Article 7(2),  eleventh  recital  a  (new) 
- a  sentence  advising  the  user  to 
consult  a  competent  homeopathic 
therapist  whilst  using  the 
medicinal  product  if the  symptoms 
persist. 
Article 8,  second  indent 
dossier  .describing 
homeopathic  stock 
is/are  obtained  and 
and  justifying 
how  the 
stocks  or 
controlled, 
its /t  h e.i r 
homeopathic  nature,  on  the  basis 
of  an  adequate  homeopathic 
bibliography;· 
-dossier  describing  how  the 
homeopathic  stock  or  stocks  is/are 
obtained  and  controlled,  and 
justifying  its/their  homeopathic 
·nature,  on  the  basis  of  an 
adequate  homeopathic  or 
anthrop6sophical  bibliography; 
Article 9(2) 
2.  A  Member  State may  introduce or 
retain  in  its  territory  specjfic 
rules  for  the  pharmacological  and 
toxicological  tests  and  clinical 
trials  of  homeopathic  medicinal 
products  other  than  those  referred 
to  in  Article  7(1)  in  accordance 
with  the  principles  and 
characteristics.  of  homeopathy  as 
practised  in  that Member  State. 
2.  A  Member  State  may  introduce  or 
retain  in  its  territory  specific 
rules·  for  the  pharmacological  a~d 
toxicological  tests  and  clinical 
trials  of  homeopathic  medicinal 
products  other  .than  those  referred 
·to·  in  Article  7(1)  in  accordance 
with  t.he  principles  and 
charactertstics~  of  homeopathy  or 
anthroposd~hic medicine  as  practised 
in  that Member  State. - 5  -
ANNEX  2  :  AMENDEMENTS  REJECTED  BY  THE  COMMISSION 
Common  position of  the  Counci I  Text  as  amended  by  Pari iament 
{Amendment  No.  3) 
Article 7(1),  third  indent 
there  is  a  sufficient  degree  of 
dilution  to  guarantee  the  safety 
of  the  preparation;  in 
particular,  the medicinal  product 
may  not  contain  either  more  than 
one  part  per  10  000 of ·the  mother 
tincture  or  more  than  1/100th  of 
the  smallest  dose  used  in 
allopathy. with  regard  to  active 
principles  whose  presence  in  an 
allopathic  medicinal  product 
results  in  the  obligation  ·to 
submit  a  doctor's  prescription. 
there  is  a  sufficient  degree  of 
dilution  to  guarantee  the  safety 
of  the  preparation;  in 
particular,  the  medicinal  product 
. may  not  contain  either  more  than 
one  part  per  10  000  of  the  raw 
material  or  more  than  1/100th -of 
the  conventional  dose  in  allopathy 
with  regard  to  active  principles 
whose  presence  in  an  allopathic 
medicinal  product  results  in  the 
obligation  to  submit  a  docto~'s 
prescription. 
(Amendment  No.  s) 
Article 7(2),  first  indent 
the  scientific  name  of  the  stock 
or  stocks  followed  by  the  degree 
of  dilution,  making  use  of  the 
symbols  of the  pharmacopoeia  used 
in  accordance  with Article  1(1): 
- the  scientific  name  of  the  stock 
or stocks  followed  by  the  strength 
or  strengths,  making  use  of  the 
symbols  of  the  pharmacopoeia  used 
in  accordance  with  Article  1(1); 
for  preparations  containing 
several  active components,  another 
name  may  also  be  used,  though 
without  indication  of  the 
therapeutic effect; 
(Amendment  No.  10) 
Article  10(2a)  (new) 
2a.  The  Commission  shall,  within 
five  years  of  the  entry  into  force 
of  this  Oi rect  1 ve,  take  or  promote 
all  measures  necessary  to  ensure 
that  the  status  of  a 1 ternat  i ve 
medicine  is  harmonized,  particularly 
in  the  following  respects: 
-adoption  of  a  Europe  a~-
Pharmacopoeia, 
- adoption  of  a  Directive  on  the 
legitimate practice of alternative 
medicines, 
~  arrangements  for  social . security 
organizations  to  refund  the  cost 
of  services  and  medicinal 
products, 
-organization  of  officially 
recognized  teaching. • 
·' 
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Re-examined  proposal  for  aCouncl I  Directive 
widening  the  scope  of Directive 81/851/EEC 
on  the  approximation of provisions  laid  down  by  law, 
regulation or  administrative action 
relating  to  veterinary medicinal  products 
and  establishing complementary  provisions  for 
homeopathic  veterinary products 
SYN  252 
On· 8  July  1992,  the  European  Parliament  examined  the  CQhlmon  Position 
reached  by  the  eounci I  or:~  ·25  February  1992  in  the  light  of  the  prof:)_osai 
mentioned  hereunder.  The  Parliament  adopted  4  amendments. 
ln. accordance  with  Article  149(2)(d)  of  the  Treaty,  the  Commission  has 
re-examined  its  proposa I  and  decided  to  accept  amendments  · 1·  and  3; 
consequently .it  rejected  amendments  2  and  4,  for  the  reasons  explained 
below.  The  amendments  accepted  by  the  Commission  are  set  out  in  Annex  1. 
The  amendments  rejected  by  the  Commission  are  at  Annex  2. 
The  purpose  of  Amendment  2  was  to  clarify  the  concept  of  a  homeopathic 
veterinary  medicine.  In  the  opinion  of. the. Commission  however,  this 
modification  would  have  the  effect  of  including,  within  the  framework  of 
the  simplified  registration  procedure,  preparations  with  a  higher 
concentration  of  active  principle;  the  potential  risks  of  toxicity  from 
these  preparations  must  be  assessed  in  accordance  with  the  procedure  set 
out  at  Article 9  of  the  Directive. 
Amendment  4  was  aimed.at  permitting,  by  derogation  from Article 7  paragraph 
2  first  indent  of  the  ·common  Posit ion,  the  use  of  a  brand  name  for 
homeopathic  veterinary  medicines  containing  several  active  components.  The 
Comission  has  not  taken  this amel')dment  on  board  since  it considers  that  the 
presentation  of  several  act.ive  components  simply  under  a  brand  name  gives 
the  impression of  a  therapeutic  effect,. whereas  the  procedure  In Article  7 
,. app I i es  on I y  to homeopathic  veterinary med,lc ines  wh lch  are .marke~ted wHhout 
a  therapeut1c  1ndication. -7--
ANNEX  1  :  AMENDEMENTS  ACCEPTED  BY  THE  COMMISSION 
Common  position of  the  Counci I  Text  as  amended  by  Par 1 i ament 
Article  1(2)a  (new) 
2(a).  Homeopathic  preparation  may 
contain,  with  the  exception  of 
catalysts.  only  homeopathic  basic 
substances  in  a  minimum  dilution  of 
~ 
Article 7(2),  first paragraph 
2.  In  addition  to  the  clear mention 
of  the words  'homeopathic veterinary 
medicinal product  registered without 
approved  therapeutic  indications 
under  a  special.  simplified 
procedure',  the  labelling and,  where 
.appropriate,  package  insert  for  the 
medicinal  products  referred  to  in 
paragraph  1  shall bear the following 
information  a.n d  no  other 
information: 
2.  In  addition  to  the  clear  mention 
of  the words  'homeopathic veterinary 
medicinal  product' , ·  the  labelling 
and,  where  appropriate,  package 
insert  for  the  medicinal  products 
referred  to  in  paragraph  1  shall 
bear  the  following  information  and 
no other information: 
ANNEX  2  AMENDEMENTS  REJECTED  BY  THE  COMMISSION 
(Amendment  No.  2) 
Article 7(1),  fourth  indent 
- there  is  a  sufficient  degree.  of 
dilution  to  guarantee  the  safety  of 
the  medicinal  product;  in 
particular,  the  medicinal  product 
may  not contain either more  than one 
part  per  1 0  OOQ  of  the  mother 
tincture or mor~ than  1/100th of  the 
smallest dose ~- in allopathy with 
regard  to  activ:~  principles  whose 
presence  in  an  allop&thic. medicinal 
product results in the obligation to 
submit. a  veteri~ry prescription. 
- there  is  a  sufficient  degree ·of 
dilution  to  guarantee  the  safety  of 
the  medicinal  product;  in 
particular,  the  medicinal  product 
may  not contain either more  than one 
part  per  1  0  000  of  the  homeopathic 
~  or  more  than  1 I 1  OOth  of  the 
dose  customarily  used  in  allopathy 
with  regard  to  active  principles 
whose  presence  in  an  allopathic 
medicinal  product  results  in  the 
obligation  to  submit  a  veterinary 
prescription. 
(Amendment  No.  4) 
Article 7(2),  first  indent 
- the  scientific  name  of  the  stock 
.. or stocks  followed  by  the degree  of 
dilution',  using  the  symbols  of  the 
pharmacopoeia  used  in  accordance 
with Article 1(1): 
- the  scientific  name  of  the  stock 
or stocks  followed  by  the potency or 
potencies,  using  the  symbols  of  the 
pharmacopeia  used·. in accordance .with 
Article  1 ( 1).  In  the  case  of 
medicinal  products  containing  more 
than  one  active  principle,  another 
name  may  also  be  used.  but  without 
stating the  therapeutic effect: 
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